Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Results
Statement
More
| Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
| 25.27 |
17.17 |
17.39 |
17.54 |
17.54 |
Share application money
Preference share capital
Reserves & surplus
| 3,220.84 |
3,152.01 |
2,867.59 |
2,443.29 |
2,123.44 |
Secured loans
Unsecured loans
Total
| 3,246.45 |
3,169.18 |
2,884.98 |
2,461.30 |
2,142.08 |
Gross block
| 2,213.88 |
2,113.52 |
2,048.20 |
1,900.81 |
1,545.55 |
Less : revaluation reserve
Less : accumulated depreciation
| 729.87 |
621.20 |
529.41 |
451.49 |
383.52 |
Net block
| 1,484.01 |
1,492.32 |
1,518.79 |
1,449.32 |
1,162.03 |
Capital work-in-progress
| 209.47 |
152.86 |
108.19 |
131.06 |
261.29 |
Investments
| 553.26 |
164.85 |
156.88 |
85.77 |
83.00 |
Current assets, loans & advances
| 2,058.05 |
1,970.46 |
1,748.20 |
1,383.00 |
1,015.19 |
Less : current liabilities & provisions
| 1,058.34 |
611.31 |
647.08 |
587.85 |
379.43 |
Total net current assets
| 999.71 |
1,359.15 |
1,101.12 |
795.15 |
635.76 |
Miscellaneous expenses not written
Total
| 3,246.45 |
3,169.18 |
2,884.98 |
2,461.30 |
2,142.08 |
Book value of unquoted investments
| 167.20 |
42.99 |
17.89 |
70.43 |
46.03 |
Market value of quoted investments
| 386.06 |
121.86 |
138.99 |
15.34 |
36.97 |
Contingent liabilities
| 91.52 |
76.44 |
168.98 |
182.41 |
306.30 |
Number of equity sharesoutstanding (Lacs)
| 1259.15 |
854.16 |
865.32 |
872.61 |
872.54 |